Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes

Heart

Volumn 90, Issue 3, 2004, Pages 270-276

  Laine, H ^b,c   Sundell, J ^a,b,c   Nuutila, P ^b   Raitakari, O T ^b   Luotolahti, M ^c   Ronnemaa T ^c   Elomaa, T ^b   Koskinen, P ^c   Knuuti, J ^b  

^a TURKU PET CENTRE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Universität Turku   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DEXAMETHASONE; GLUCOCORTICOID; INSULIN; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEART PERFORMANCE; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 1342343980     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.013722     Document Type: Article

References (37)

1. Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998;41:369-79.
2. Sundell J, Nuutila P, Laine H, et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 2002;51:1125-30.
3. Laine H, Nuutila P, Luotolahti M, et al. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J Clin Endocrinol Metab 2000;85:1868-73.
4. Sundell J, Laine H, Nuutila P, et al. The effects of insulin and short-term hyperglycemia on myocardial blood flow in young men with uncomplicated Type I diabetes. Diabetologia 2002;45:775-82.
5. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46.
6. Malmberg K, Norhammar A, Wedel H, et al. Glycometobolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 1999;99:2626-32.
7. Marano L, Bestetti A, Lomuscio A, et al. Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol 2000;55:9-15.
8. Maki M, Luotolahti M, Nuutila P, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996;93:1658-66.
9. Scherrer U. Insulin and the regulation of cardiovascular system: role of the L-arginine nitric oxide pathway and the sympathetic nervous system. In: Lüscher TE, ed. The endothelium in cardiovascular disease. Heidelberg: Springer Verlag, 1995:108-28.
10. Sobrevia L, Nadal A, Yudilevich DL, et al. Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol 1996;490:775-81.
11. Opie LH. The heart, 3rd ed. Philadelphia: Lippincott-Raven, 1998.
12. Ewing DJ, Campbell IW, Clarke BF. Mortality in diabetic autonomic neuropathy. Lancet 1976;i:601-3.
13. Ewing DJ, Boland O, Neilson JM, et al. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991;34:182-5.
14. Bellavere F, Cacciatori V, Moghetti P, et al. Acute effect of insulin on autonomic regulation of the cardiovascular system: a study by heart rate spectral analysis. Diabet Med 1996;13:709-14.
15. van de BP, Hausberg M, Hoffman RP, et al. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999;276:R178-83.
16. Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997;336:1208-15.
17. Di Carli MF, Bianco-Batlles D, Landa ME, et al. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999;100:813-9.
18. Allman KC, Stevens MJ, Wieland DM, et al. Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 1993;22:1425-32.
19. Stevens MJ, Raffel DM, Allman KC, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998;98:961-8.
20. Saraste M, Koskenvuo J, Knuuti J, et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001;21:114-22.
21. Scherrer U, Vollenweider P, Randin D, et al. Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 1993;88:388-94.
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
23. Clark K, Crouzel C, Meyer GJ, et al. Current methodology for oxygen-15 production for clinical use. Int J Rad Appl Instrum [A] 1987;38:597-600.
24. Crouzel C, Clark J, Brihaye C, et al. Radiochemistry automation for PET. In: Stöckling G, Pike V, eds. Radiopharmaceuticals for positron emission tomography. Dordrecht: Kluwer Academic, 1993:45-90.
25. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cordial 1998;32:147-53.
26. Iida H, Takahashi A, Tamura Y, et al. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995;36:78-85.
27. Iida H, Rhodes CG, de Silva R, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992;33:1669-77.
28. Piha SJ. Cardiovascular autonomic reflex tests: normal responses and age-related reference values. Clin Physiol 1991;11:277-90.
29. Kadish A, Little R, Sternberg J. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968;14:116-31.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipaprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. Scheinin M, Karhuvaara S, Ojala-Karlsson P, et al. Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci 1991;49:75-84.
32. Nitenberg A, Valensi P, Sachs R, et al. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993;42:1017-25.
33. Pitkanen OP, Nuutila P, Raitakari OT, et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998;47:248-54.
34. Akasaka T, Yoshida K, Hozumi T, et al. Retinopathy identifies marked restriction of coronary flow reserve in patients with diabetes mellitus. J Am Coll Cardiol 1997;30:935-41.
35. Buus NH, Bottcher M, Hermansen F, et al. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001;104:2305-10.
36. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997;96:4104-13.
37. Takeshita A, Mark AL. Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 1980;2:610-6.